Rosuvastatin (Crestor) Reduced Blood Clot Risk

A large trial of the cholesterol lowering drug rosuvastatin (Crestor from AstraZeneca) showed that giving it to healthy adults reduced their risk of blood clots (venous thromboembolism) by 43 per cent.

More: continued here

Filed under: Cholesterol on March 31st, 2009